Related Experiment Video
Updated: May 11, 2026

Isolation, Culture, and Characterization of Primary Dermal Fibroblasts from Human Keloid Tissue
Published on: July 28, 2023
Effects of botulinum toxin type A on expression of genes in keloid fibroblasts
Wang Xiaoxue1, Chen Xi, Xiao Zhibo
1Second Affiliated Hospital of the Harbin Medical University, Harbin City, China.
Background:
Invasive growth of fibroblast cells, which is regulated by multiple biological factors, is the key event in the pathophysiology of keloid scars. Recent studies have suggested that botulinum toxin type A (BoNT-A) could inhibit invasive growth of keloids. However, the molecular mechanisms are unknown.
Objective:
The authors explore the effect of BoNT-A on the expression of genes relevant to invasive growth in keloid fibroblasts.
Methods:
With 112 genes that were relevant to invasive growth, the authors utilized microarray analysis to study messenger RNA expression profiles in keloid fibroblasts treated with BoNT-A. Quantitative real-time polymerase chain reaction (qRT-PCR) was performed to confirm the microarray results.
Results:
Analyses from microarray and qRT-PCR revealed that the S100A4 gene was upregulated and that the TGF-β1, VEGF, MMP-1, and PDGFA genes were downregulated in fibroblasts treated with BoNT-A.
Conclusions:
The BoNT-A altered expression levels of S100A4, TGF-β1, VEGF, MMP-1, and PDGFA genes in keloid fibroblasts provide a useful clue for exploring the function of BoNT-A and finding a novel treatment for keloid scarring.
Insights
Botulinum toxin type A (BoNT-A) alters gene expression in keloid fibroblasts, downregulating key growth factors like TGF-β1 and VEGF. This finding offers insights into BoNT-A's mechanism for treating keloid scars.
Area of Science:
- Dermatology and Molecular Biology
Background:
- Keloid scars involve invasive fibroblast growth, a process influenced by various biological factors.
- Botulinum toxin type A (BoNT-A) shows potential in inhibiting keloid invasive growth, but its molecular mechanisms require elucidation.
Purpose of the Study:
- To investigate the impact of BoNT-A on the expression of genes associated with invasive growth in keloid fibroblasts.
Main Methods:
- Microarray analysis was employed to assess messenger RNA expression profiles of 112 genes related to invasive growth in BoNT-A-treated keloid fibroblasts.
- Quantitative real-time polymerase chain reaction (qRT-PCR) was utilized to validate the microarray findings.
Main Results:
- BoNT-A treatment led to the upregulation of the S100A4 gene.
- Conversely, BoNT-A downregulated the expression of TGF-β1, VEGF, MMP-1, and PDGFA genes in keloid fibroblasts.
Conclusions:
- The observed alterations in S100A4, TGF-β1, VEGF, MMP-1, and PDGFA gene expression by BoNT-A provide valuable insights into its functional role.
- These findings suggest potential novel therapeutic strategies for keloid scarring by targeting these specific genes.
Related Concept Videos
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Introduction to Fibroblasts
Bacterial Toxins
TGF - β Signaling Pathway
Induced Pluripotent Stem Cells
Somatic cells are...
